1. Home
  2. DRUG vs ELMD Comparison

DRUG vs ELMD Comparison

Compare DRUG & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • ELMD
  • Stock Information
  • Founded
  • DRUG 2019
  • ELMD 1992
  • Country
  • DRUG United States
  • ELMD United States
  • Employees
  • DRUG N/A
  • ELMD N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • DRUG Health Care
  • ELMD Health Care
  • Exchange
  • DRUG Nasdaq
  • ELMD Nasdaq
  • Market Cap
  • DRUG 233.2M
  • ELMD 229.6M
  • IPO Year
  • DRUG N/A
  • ELMD 2010
  • Fundamental
  • Price
  • DRUG $33.19
  • ELMD $22.13
  • Analyst Decision
  • DRUG Strong Buy
  • ELMD Strong Buy
  • Analyst Count
  • DRUG 5
  • ELMD 1
  • Target Price
  • DRUG $83.25
  • ELMD $38.00
  • AVG Volume (30 Days)
  • DRUG 25.6K
  • ELMD 44.8K
  • Earning Date
  • DRUG 05-20-2025
  • ELMD 05-13-2025
  • Dividend Yield
  • DRUG N/A
  • ELMD N/A
  • EPS Growth
  • DRUG N/A
  • ELMD 66.51
  • EPS
  • DRUG N/A
  • ELMD 0.75
  • Revenue
  • DRUG N/A
  • ELMD $59,626,000.00
  • Revenue This Year
  • DRUG N/A
  • ELMD $17.91
  • Revenue Next Year
  • DRUG N/A
  • ELMD $11.70
  • P/E Ratio
  • DRUG N/A
  • ELMD $30.16
  • Revenue Growth
  • DRUG N/A
  • ELMD 15.35
  • 52 Week Low
  • DRUG $0.93
  • ELMD $13.74
  • 52 Week High
  • DRUG $79.02
  • ELMD $35.56
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 51.77
  • ELMD 39.33
  • Support Level
  • DRUG $29.59
  • ELMD $21.81
  • Resistance Level
  • DRUG $32.75
  • ELMD $23.50
  • Average True Range (ATR)
  • DRUG 1.99
  • ELMD 0.69
  • MACD
  • DRUG 0.14
  • ELMD 0.03
  • Stochastic Oscillator
  • DRUG 54.42
  • ELMD 21.93

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Share on Social Networks: